Differentiation therapy using low-dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16-RARA. Li H, Xiang X, Ding H, Yu J, et al. Br J Haematol 2022;199:768-771.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li H, Xiang X, Ding H, Yu J, et al. Differentiation therapy using low-dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16-RARA. Br J Haematol 2022;199:768-771.
PMID: 36169236